Sercloremine
From Wikipedia, the free encyclopedia
| Sercloremine | |
|---|---|
 |
|
|
4-(5-Chloro-1-benzofuran-2-yl)-1-methylpiperidine |
|
| Identifiers | |
| CAS number | 54403-19-9  [1] |
| PubChem | 162748 |
| ChemSpider | 142883 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C14H16ClNO |
| Molar mass | 249.74 g mol−1 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references |
Sercloremine, usually as a hydrochloride, is an experimental drug candidate under study as an antidepressant[2]. This drug was developed by Novartis and is in Phase II clinical trials.[3]
References
- ^ "Chemical data". guidechem. http://www.guidechem.com/products/54403-19-9.html. Retrieved July 29, 2011.
- ^ US Patent 4600719 - Tetrahydropyridine and piperidine derivatives
- ^ "Chemdrug data page" (in Japanese, and English). Chemdrug. http://www.chemdrug.com/databases/8_0_rkjojsliimsfrkxv.html. Retrieved July 29, 2011.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
